Azlocillin: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
m Undid revision 649815405 by 80.42.29.75 (talk) revert edits by sock of blocked editor Nuklear |
||
Line 50: | Line 50: | ||
* ''Haemophilus'' spp. 0.03 μg/mL - 2 μg/mL |
* ''Haemophilus'' spp. 0.03 μg/mL - 2 μg/mL |
||
* ''Pseudomonas aeruginosa'' 4 μg/mL - 6.25 μg/mL |
* ''Pseudomonas aeruginosa'' 4 μg/mL - 6.25 μg/mL |
||
==Synthesis== |
|||
[[File:Azlocillin synthesis.svg|thumb|center|700px|Azlocillin synthesis: {{Cite patent|FR|2100682}} eidem {{US patent|3933795}} <ref>H. B. Konig et al., Eur. J. Med. Chem. - Chim. Ther. 17, 59 (1982).</ref>]] |
|||
==References== |
==References== |
||
{{reflist|30em}} |
{{reflist|30em}} |
Revision as of 12:18, 4 March 2015
This article needs additional citations for verification. (August 2013) |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.048.483 |
Chemical and physical data | |
Formula | C20H23N5O6S |
Molar mass | 461.491 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Azlocillin is an acylampicillin antibiotic with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin is similar to mezlocillin and piperacillin. It demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa and, in contrast to most cephalosporins, exhibits activity against enterococci.
Spectrum of bacterial susceptibility
Azlocillin is considered a broad spectrum antibiotic and can be used against a number of Gram positive and Gram negative bacteria. The following represents MIC susceptibility data for a few medically significant organisms.[1]
- Escherichia coli 1 μg/mL - 32 μg/mL
- Haemophilus spp. 0.03 μg/mL - 2 μg/mL
- Pseudomonas aeruginosa 4 μg/mL - 6.25 μg/mL
References